GSK3B and malignant colon neoplasm: In ovarian cancer cells, emodin inhibited the EMT process through the ILK/GSK-3β/Slug signaling pathway [111], while in colon cancer cells, emodin inhibited cell invasion and migration by suppressing EMT via the Wnt/β-catenin pathway [112].